• Nirmatrelvir (PF-07321332): Assay Design Guide

  2026-08-31

  Nirmatrelvir (PF-07321332) is a precise SARS-CoV-2 3CL protease inhibitor for connecting molecular mechanism with decision-grade antiviral assays. This guide moves beyond docking summaries to explain experimental design, controls, product handling, and evidence interpretation in COVID-19 research.

• Panobinostat and the Logic of Cell Death Assays

  2026-08-31

  Panobinostat (LBH589) is more than a potent HDAC inhibitor: it is a tool for separating chromatin remodeling, transcriptional stress, and regulated apoptosis. This article translates recent RNA Pol II biology into mechanism-aware assay strategies for cancer and epigenetics research.

• EZ Cap™ Cy5 EGFP mRNA: Two-Axis Assay

  2026-08-30

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables a two-axis mRNA delivery and translation efficiency assay. This article shows how to separate cellular uptake from functional expression and use reporter data to optimize carrier chemistry.

• Bradford Protein Assay Kit K4103: Practical Guide

  2026-08-29

  The Bradford Protein Assay Kit (SKU K4103) provides rapid colorimetric protein concentration measurement from small volumes using Coomassie Brilliant Blue G-250 and supplied BSA standards. It is appropriate for soluble samples in the stated working range, but detergent-rich, strongly chaotropic, compositionally atypical, or out-of-range samples require compatibility testing and careful interpretation.

• Doxorubicin Hydrochloride: Mechanism to Assay

  2026-08-29

  Doxorubicin hydrochloride and Adriamycin HCl are powerful tools for linking DNA damage, metabolic stress, apoptosis, and cardiac injury. This guide presents a mechanism-to-assay framework grounded in a thymoquinone cardiotoxicity study to improve interpretation and reproducibility.

• CD38 CAR Binder Structures and Affinity Tuning

  2026-08-28

  Cheng and colleagues combine structural biology, alanine scanning, enzyme assays, and CAR-T functional testing to show that CD38 binders RP02 and 028 engage different antigen surfaces and produce distinct effects on CD38 catalysis. The study further demonstrates that a rationally attenuated 028 variant can reduce CAR-T fratricide while preserving cytotoxicity, establishing a structure-guided framework for tuning potency and selectivity.

• CHK1 Inhibition in ER/PR-Stratified Breast Cancer

  2026-08-28

  The reference study shows that CHK1 inhibition does not have a uniform effect across breast cancer subtypes defined by oestrogen-receptor, progesterone-receptor, and HER2 status. Its main practical contribution is a subtype-aware treatment framework: CHK1 inhibition can enhance adriamycin sensitivity in ER−/PR−/HER2− disease but acts mainly as a single-agent strategy in ER+/PR+/HER2− models.

• Meropenem in Carbapenem Resistance Workflows

  2026-08-27

  Meropenem supports reproducible susceptibility testing, resistance-mechanism profiling, and Gram-negative infection model design. This guide connects β-lactam pharmacology with plasmid-focused surveillance workflows and practical troubleshooting for carbapenem-resistant bacterial infections.

• GKT137831: Dual Nox1/Nox4 Inhibitor Workflows

  2026-08-27

  GKT137831 provides a practical way to dissect Nox1/Nox4-driven oxidative stress in vascular, fibrotic, and metabolic models. This workflow-focused guide shows how to combine redox measurements with membrane-integrity and ferroptosis assays without overstating what the compound proves mechanistically.

• Rifampin: Mechanism and Research Workflows

  2026-08-26

  Rifampin is a rifamycin antibiotic and bacterial DNA-dependent RNA polymerase inhibitor used to interrogate transcription, resistance, and synthetic biology systems. Its value depends on organism susceptibility, controlled DMSO handling, and separating bacterial transcription experiments from mammalian optogenetic translation platforms.

• Cardiogreen (Indocyanine Green) Assay Guide

  2026-08-26

  A scenario-based guide to using Cardiogreen (Indocyanine Green), SKU B8315, in cell viability, proliferation, cytotoxicity, and photodynamic workflows. It connects formulation data, optical controls, protocol parameters, and recent phototherapy evidence to improve experimental interpretation.

• 5-Azacytidine A1907: Reliable Assay Workflows

  2026-08-25

  A practical, scenario-driven guide to using 5-Azacytidine (SKU A1907) in viability, proliferation, cytotoxicity, and DNA-methylation experiments. It connects mechanism, solvent handling, time-course design, data interpretation, and evidence-based product selection for more defensible results.

• HyperTrap Heparin HP Column for Cancer Research

  2026-08-25

  The HyperTrap Heparin HP Column combines a fine-particle heparin matrix with ready-to-use operation for selective biomolecule enrichment. This workflow-focused guide shows how to apply it to coagulation proteins, growth-factor studies, and soluble-factor investigations inspired by CCR7–Notch1 cancer stemness research.

• USP42, JNK/p38 Signaling, and Breast Cancer Apoptosis

  2026-08-24

  The reference study identifies USP42 as a potential driver of breast cancer progression by connecting its elevated expression to reduced JNK/p38 activation and impaired apoptosis. Its combination of loss-of-function experiments, pathway-inhibitor rescue, and xenograft validation provides a useful framework for evaluating USP42 as a mechanistic and therapeutic target.

• Mycophenolic Acid: Dehydrogenase Inhibitor Guide

  2026-08-23

  Mycophenolic acid is a research-grade dehydrogenase inhibitor that targets inosine monophosphate dehydrogenase and thereby perturbs guanine nucleotide biosynthesis. Product specifications and a standardized whole-blood immunometabolism protocol support its use in controlled metabolic, cytokine, apoptosis, and immune-response studies, but not as a diagnostic or medical product.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page